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Normal appearing white matterSystemic lupus erythematosus (SLE) is an autoimmunediseasewithmulti-organ involvement and results in neu-
rological and psychiatric (NP) symptoms in up to 40% of the patients. To date, the diagnosis of neuropsychiatric
systemic lupus erythematosus (NPSLE) poses a challenge due to the lack of neuroradiological gold standards. In
this study, we aimed to better localize and characterize normal appearing white matter (NAWM) changes in
NPSLE by combining data from two quantitative MRI techniques, diffusion tensor imaging (DTI) and magnetiza-
tion transfer imaging (MTI). 9 active NPSLE patients (37±13years, all females), 9 SLE patientswithout NP symp-
toms (44 ± 11 years, all females), and 14 healthy controls (HC) (40 ± 9 years, all females) were included in the
study. MTI, DTI and ﬂuid attenuated inversion recovery (FLAIR) images were collected from all subjects on a 3 T
MRI scanner. Magnetization transfer ratio (MTR), mean diffusivity (MD), fractional anisotropy (FA), radial diffu-
sivity (RD), axial diffusivity (AD)maps andwhitematter lesionmaps based on the FLAIR imageswere created for
each subject. MTR andDTI datawere then co-analyzed using tract-based spatial statistics and a cumulative lesion
map to exclude lesions. Signiﬁcantly lower MTR and FA and signiﬁcantly higher AD, RD and MD were found in
NPSLE compared toHC inNAWMregions. The differences inDTImeasures and inMTR, however,were onlymod-
erately co-localized. Additionally, signiﬁcant differences in DTI measures, but not in MTR, were found between
NPSLE and SLE patients, suggesting that the underlying microstructural changes detected by MD are linked to
the onset of NPSLE. The co-analysis of the anatomical distribution of MTI and DTI measures can potentially im-
prove the diagnosis of NPSLE and contribute to the understanding of the underlying microstructural damage.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Systemic lupus erythematosus (SLE) is a relapsing–remitting
female-predominant autoimmune disease affecting multiple organs
(Stojanovich et al., 2007; Kozora and Filley, 2011; Lauvsnes and; AD, axialdiffusivity;DTI,diffu-
attenuated inversion recovery;
iontransferimaging;MTR,mag-
atter;NP,neurologicalandpsy-
tosus; RD, radial diffusivity; SLE,
istics;WM,whitematter;WMH,
, C3Q, Albinusdreef 2, 2333 ZA
(0)71 524 825.
. This is an open access article underOmdal, 2012; Jeltsch-David and Muller, 2014). Neuropsychiatric (NP)
events are common in SLE but only in 40% of these cases the symptoms
can be directly attributed to SLE (Castellino et al., 2008; Bertsias and
Boumpas, 2010; Kozora and Filley, 2011). SLE-associated NP syndromes
are very heterogeneous, ranging from mild symptoms, such as head-
aches and mood disorders, to severe NP syndromes, such as seizures,
and psychosis (Appenzeller et al., 2007; Bertsias and Boumpas, 2010;
Kozora and Filley, 2011; Lauvsnes and Omdal, 2012). The presentation
of NP complaints in a patient with SLE continues to pose a diagnostic
challenge to practicing physicians, mainly due to the absence of ade-
quate diagnostic tests for NPSLE, resulting in an inconclusive diagnosis
in a signiﬁcant number of cases (Welsh et al., 2007; Appenzeller et al.,
2008a; Bertsias and Boumpas, 2010).
Magnetic resonance imaging (MRI) has emerged as a promising tech-
nique to study NPSLE, as T2-weighted and ﬂuid-attenuated inversionthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Demographics of the study subjects and patient characteristics from SLE and NPSLE
patients.
NPSLE patients SLE patients Healthy controls
(n = 9 females) (n = 9 females) (n = 14 females)
Age (years) 37 ± 13 44 ± 11 40 ± 9
SLE disease duration (years) 10 ± 9 11 ± 8 −
NPSLE disease duration
(years)
1 ± 2 − −
SLEDAI 4 ± 5 2 ± 2 −
Patient characteristics
Antiphospholipid
syndrome
3 (33%) 1 (11%)
Active NPSLE patients 7 (78%) −
Inﬂammatory phenotype 6 (67%) −
Ischemic phenotype 6 (67%) −
Auto-antibodies
Antinuclear antibody 9 (100%) 9 (100%)
Anti-DNA 2 (22%) 7 (78%)
Anti-RNP 2 (22%) 1 (11%)
Anti-SSA 3 (33%) 4 (44%)
Anti-SSB 1 (11%) 1 (11%)
Anti-Smith 1 (11%) 0
Anticardiolipin
autoantibodies
1 (11%) 2 (22%)
Lupus anticoagulant 3 (33%) 2 (22%)
Anti-B2 glycoprotein 2 (22%) 0
ACR criteria
Malar rash 3 (33%) 2 (22%)
Discoid lupus 3 (33%) 3 (33%)
Photosensitivity 4 (44%) 5 (56%)
Aphthosis 5 (56%) 3 (33%)
Arthritis 8 (89%) 7 (78%)
Serositis 1 (11%) 3 (33%)
Lupus nephritis 1 (11%) 3 (33%)
NPSLE 9 (100%) 0
Hematologic disorder 6 (67%) 7 (78%)
Immunologic disorder 6 (67%) 9 (100%)
Antinuclear antibodies 9 (100%) 9 (100%)
Medication
Prednisone 7 (78%) 3 (33%)
Azathioprine 1 (11%) 4 (44%)
Methotrexate 0 1 (11%)
Hydroxychloroquine 5 (56%) 8 (89%)
Rituximab 1 (11%) 0
338 E. Ercan et al. / NeuroImage: Clinical 8 (2015) 337–344recovery (FLAIR) scans have revealed focal hyperintense lesions, which
are present in deep, periventricular and subcortical white matter (WM)
in up to 70% of NPSLE patients (Appenzeller et al., 2008a; Appenzeller
et al., 2008b; Castellino et al., 2008; Kozora and Filley, 2011; Luyendijk
et al., 2011). Although they are common among NPSLE patients, these
white matter hyperintensities (WMH) are non-speciﬁc and can be
found in a variety of groups of SLE patients, including those with active
NPSLE (SLE patients with active NP symptoms), SLE patients with NP ep-
isodes in their past (inactive NPSLE), and SLE patients with no NP symp-
toms as well as in many other conditions unrelated to SLE, such as aging,
multiple sclerosis, and cerebral small vessel disease (Luyendijk et al.,
2011). Recent studies also showed that 42–47% of the patients with
NPSLE do not have any visible MRI abnormalities, suggesting that the
link between FLAIR abnormalities and the etiology of NPSLE is tenuous
(Luyendijk et al., 2011; Steup-Beekman et al., 2013).
Quantitative MRI techniques such as diffusion weighted imaging
(DWI), diffusion tensor imaging (DTI) andmagnetization transfer imag-
ing (MTI) have been shown to be sensitive to diffuse alterations in the
brain of NPSLE patients, and can be evaluated by quantitative maps of,
e.g. mean diffusivity (MD) and fractional anisotropy (FA) of DTI, or
other methods, such as histograms of these quantities and of magneti-
zation transfer ratio (MTR) (Bosma et al., 2000b; Bosma et al., 2003;
Emmer et al., 2006; Hughes et al., 2007; Welsh et al., 2007; Zhang
et al., 2007; Emmer et al., 2010; Jung et al., 2010; Schmidt-Wilcke
et al., 2014). Previous MTI studies of NPSLE patients showed lower
peak heights in both whole brain and tissue speciﬁc MTR histograms
compared to healthy controls (HC), suggesting either demyelination
or an increase in free water resulting from cytotoxic or vasogenic
edema (Bosma et al., 2000b; Emmer et al., 2006). These alterations
were also shown to correlate with reversible changes in outcome of pa-
tients with active symptoms (Bosma et al., 2000a). In a separate DTI
study that used tract based spatial statistics (TBSS), higher MD and
lower FA in WM were reported for NPSLE patients compared to HC,
also suggesting a diffuse microstructural basis for the NP symptoms
(Emmer et al., 2010).
Although MRI is sensitive to changes associated with NPSLE, no
single technique is shown to be speciﬁc enough to serve as a diagnostic
tool for both the diffuse and focal changes in the brain. A few studies
have utilized multimodal analysis of several MRI techniques, including
FLAIR, T1-weighted and T2-weighted images, MTI and DTI, to under-
stand the etiology of NPSLE (Bosma et al., 2004; Emmer et al., 2008;
Zivadinov et al., 2013; Zimny et al., 2014). These studies, however
promising, were limited to showing only global changes in the whole
brain or in total normal appearing brain tissue. No study to date
employed a voxel-based combination and comparison of different
quantitative MRI maps to study NPSLE to investigate the anatomical
distribution of tissue damage in NPSLE as reﬂected by DTI and MTI, as
well as the relationship between microstructural damage in normal
appearing white matter (NAWM) and WMH.
In this studywe simultaneously assessed and combined quantitative
information fromMTI, DTI and FLAIR images to better localize and char-
acterizeWM changes in SLE and in NPSLE. In this way we aim to obtain
more information on the underlying pathological processes driving
NPSLE, and compare the diagnostic potential of FLAIR, DTI and MTI
whether separately applied or combined.
2. Materials and methods
2.1. Patients and healthy controls
9 NPSLE patients (37 ± 13 years), 9 SLE patients without NP symp-
toms (44 ± 11 years) and 14 age-matched HC without known neuro-
logical abnormalities or autoimmune diseases (40 ± 9 years) were
included in the study. All subjects were female. The study was in com-
pliance with Helsinki Declaration and approved by Institutional Review
Board of Leiden University Medical Center (LUMC). All subjectsprovided a written informed consent. All SLE and NPSLE patients were
recruited from the Department Of Rheumatology at our institution
and had been diagnosed with SLE according to the 1982 revised
American College Of Rheumatology (ACR) criteria (Tanet al., 1982;
Hochberg, 1997). NPSLE diagnosis was made after exclusion of other
causes by multidisciplinary consensus. NP diagnoses were classiﬁed ac-
cording to the 1999 ACR case deﬁnitions for NPSLE syndromes and each
NPSLE patient was categorized according to the presence of inﬂamma-
tory and/or ischemic syndromes (American College of Rheumatology,
1999; Zirkzee et al., 2012). TheNPSLE subjects had at least oneof the fol-
lowing central nervous systemNP syndromes: psychosis (n=1), head-
ache (n= 5), movement disorder (n= 1), transverse myelitis (n= 1),
seizure (n= 1), anxiety (n= 1), cognitive disorder (n= 4) and mood
disorder (n = 3). Demyelinating syndrome, aseptic meningitis and
acute confusional statewere not present in our group of NPSLE patients.
Table 1 shows the clinical characteristics, the autoantibody proﬁle and
the medication of the study subjects at the time of the MRI.
2.2. Data acquisition
MRI scans were performed on a 3 Tesla Achieva Philips MRI scanner
(Philips Healthcare, Best, The Netherlands) equipped with an 8-
channel receive head coil. MRI scan protocol consisted of (a) Axial
339E. Ercan et al. / NeuroImage: Clinical 8 (2015) 337–3443D T1-weighted images (FOV: 224 × 177 × 144, resolution:
0.88 × 0.88 × 1.20 mm3, TR/TE = 9.75/4.59 ms); (b) Sagittal FLAIR
images (FOV: 220 × 173 × 220, resolution: 0.98 × 0.98 × 1.12 mm3,
TR/TE/TI = 4800/274/1650 ms); (c) Axial Diffusion Tensor Images
(DTI) (FOV: 224 × 224 × 120, resolution: 2 × 2 × 2 mm3, TR/TE =
8500/95 ms, one b = 0 s/mm2 volume and 15 diffusion-weighted
volumes with a b-value of 1000 s/mm2); (d) Axial MTI (FOV:
230 × 230 × 132, resolution: 1.44 × 1.44 × 1.5 mm3, TR/TE =
57.07/10.00 ms, ﬂip angle: 15°, two sets of images acquired with and
without a sinc-gauss radio frequency saturation pulse of 25 ms duration,
peak B1 amplitude of 5.283 µT and offset frequency of 2000 Hz).
2.3. Image processing and analysis
2.3.1. FLAIR lesion segmentation
WM hyperintensities were manually segmented from the FLAIR
images by an expert reader (O.T.) and binary lesionmasks were created
for each subject using MIPAV (Medical Image Processing, Analysis and
Visualization) software (McAuliffe et al., 2001; Bazin et al., 2007). All
FLAIR images were afﬁne registered to MNI152 standard space using
FSL FLIRT (Jenkinson and Smith, 2001; Jenkinson et al., 2002). The
same transformation matrix was applied to align individual lesion
masks to the standard space. Cumulative lesion masks were created
for NPSLE patients, SLE patients and HC by adding all individual lesion
masks from each group in standard space.
2.3.2. DTI post-processing
The diffusion-weighted images were brain-extracted with the BET
tool in FSL (http://www.fmrib.ox.ac.uk/fsl). Using an estimate of the
noise variance in CSF signal intensity of the right ventricle, the data
were denoised using an algorithm described in Aja-Fernandez et al.
(2008) and then Rician noise corrected using the algorithm in Ingo
et al. (2014). The data were corrected for motion and eddy currents
by co-registering diffusion weighted images to the image acquired
with b = 0 s/mm2 using the SPM8 toolbox (http://www.ﬁl.ion.ucl.ac.
uk/spm/software/spm8/). The same transformation matrix was applied
to the diffusion gradient directions to rotate them according to the reg-
istration algorithm. DTI metrics were estimated on a voxel-wise basis
using Diffusion Toolbox (FDT) (Behrens et al., 2003). In order to have
an initial alignment between all subjects, each subject3s FA map was
ﬁrst registered to the FA map of one representative HC through a rigid
registration with 6 degrees of freedom. FA maps were then used as an
input to the TBSS process (Smith et al., 2006) where all FA maps were
registered to the FSL FA template in MNI standard space through non-
linear registration, and a mean FA image was created from the average
of all individual FA images. The mean FA image was then skeletonized,
and a threshold of 0.25 was applied to the skeleton to exclude non-
WM voxels. All individual FA maps were then projected onto this com-
mon skeleton by using the maximum FA value perpendicular to the
skeleton voxels. The same transformations and projections were ap-
plied to the other DTI maps, such as MD, radial diffusivity (RD) and
axial diffusivity (AD).
2.3.3. MTI post-processing
An in-house FSL script was used for the processing of the MTI data.
The image without saturation (M0) was brain-extracted using BET and
the binary brain mask obtained from BET was applied to the image
with saturation (Ms).Mswas then aligned toM0with normalizedmutu-
al information algorithm using 7 degrees of freedom in FSL FLIRT. The
magnetization transfer ratio (MTR) was calculated as a percentage on
a voxel-wise basis according to the following equation:
MTR ¼ M0−Ms
M0
 100
where Ms is the voxel intensity with saturation and M0 is the voxel in-
tensity without saturation. In order to align the MTR images with theFA images, the unsaturated image was co-registered to the image at
b=0 s/mm2 through afﬁne registration using normalizedmutual infor-
mation, following the procedure described in Bodini et al. (2014). The
same transformation matrix was then used to align the MTR images
with the FA images. Finally, the same MNI transformations and projec-
tions used in the DTI post-processing were applied to MTR.
2.3.4. Statistical analysis
Permutation tests were applied to 4D skeletonized FA, MD, AD, RD
and MTR images in order to assess voxel-wise statistics between
NPSLE patients, SLE patients, and HC. 5000 permutations were used
and corrected for multiple comparison based on TFCE (Threshold-Free
Cluster Enhancement) (Winkler et al., 2014). Age related changes be-
tween groupswere corrected by using demeaned age of each individual
as a covariate in the TBSS process. In order to assess the statistical differ-
ences between NPSLE, SLE, and HC on WM voxels, ANOVA tests were
performed with a threshold of p-value b 0.05 on FA, MD, AD, RD and
MTR maps. Mann–Whitney U tests were applied to the statistical com-
parisons of the number and normalized volume of WMH between
NPSLE, SLE and HC groups in IBM SPSS Statistics for Windows, Version
20.0 (IBM Corp. Released 2011, Armonk, NY, US).
2.3.5. Co-analysis of DTI and MTR data
An in-house developed MATLAB® (Mathworks, Natick MA, USA)
code was used to assess the overlap of signiﬁcant differences between
AD, FA, MD, RD and MTR in the different subject cohorts. FSL volumes
containing the voxel-wise statistics corrected for age andmultiple com-
parisons were used as an input for the co-analysis. Voxels with a p-
value b 0.05 that overlapped in any two of the above metrics were
counted and divided by the total number of voxels in the skeletonized
WM in order to compute the ratio of overlap between signiﬁcantly dif-
ferent regions in these two metrics. The mismatch between MTR and
each DTI metric was also similarly assessed in order to ﬁnd the regions
with only MTR or DTI differences between groups.
2.3.6. Histogram analysis
In order to relate the current data to the histogram ﬁndings in previ-
ous works, we generated histograms based on the MD and MTR voxel-
wise values in the skeletonizedWMof the three subject groups. The fol-
lowing steps were followed, using an in-house developed MATLAB
script: in order to generate histograms based only on NAWM, MTR,
and MD, skeletonized images from all subjects were individually
masked in MNI space with the lesion masks. Subsequently, MTR and
MD histograms were created for each subject. All histograms were nor-
malized by the total number of NAWM voxels in the skeleton for each
individual subject. Peak height and locations were then calculated for
each normalized histogram. Average histograms of MD and MTR in
NAWM were then created for SLE, NPSLE and HC groups separately.
The statistical comparisons of the histogram peak height and locations
betweenNPSLE, SLE andHCgroupswereperformedwithMann–Whitney
U tests in SPSS software.
3. Results
3.1. Co-analysis of MTR and DTI data
Fig. 1 shows the comparison of FA, MD, AD, RD, and MTR between
NPSLE patients and HC (top row), and between SLE and NPSLE patients
(bottom row) on one axial slice in MNI152 space. NPSLE patients
showed signiﬁcantly higher AD, RD and MD, and lower FA and MTR
than both HC and SLE patients. Cumulative WM lesion maps computed
for NPSLE patients and SLE patients are the top and bottom rightmost
panels in Fig. 1 respectively.
Table 2 shows the fractions of the total number of voxels in the skel-
etonized WM with signiﬁcant differences in the various DTI measures
and in MTR between NPSLE and HC (top rows) and between NPSLE
Fig. 1. Comparison of statistically signiﬁcant differences (p-value b 0.05) in FA,MD, AD, RD, andMTR between NPSLE patients and healthy controls (top row), and between SLE and NPSLE
patients (bottom row) on one axial slice inMNI152 space. The mean FA skeleton is shown in green, regions with higher values in the NPSLE patients compared to SLE or HC are shown in
blue and regions with lower values in NPSLE patients compared to SLE or HC are shown in red. Yellow arrow shows one of the regions (i.e. genu of the corpus callosum) where extensive
differences were observed in RD, MD and FA but not in MTR. Cumulative WM lesion maps from NPSLE patients (top rightmost image) and SLE patients (bottom rightmost image) are
shown in orange.
340 E. Ercan et al. / NeuroImage: Clinical 8 (2015) 337–344and SLE (bottom rows). The diagonal elements in the table represent
the volume fraction of signiﬁcant voxels of any single modality, and
the off-diagonal elements represent the volume fractions of overlap be-
tween two modalities. For example, voxels with signiﬁcant differences
in MD between NPSLE and HC comprised 42% of the skeletonized
WM, whereas voxels with signiﬁcant differences between NPSLE and
HC in both MD and MTR comprised 14% of the skeletonized WM.3.1.1. MTR results
Widespread differences in MTR values (MTR(NPSLE) b MTR(HC) in
28% of theWM skeleton) were observed between NPSLE and HC. Strik-
ingly, as opposed to the extensive differences in DTI metrics between
NPSLE and SLE subjects, few differences in MTR were found between
these two groups. There were no statistically signiﬁcant differences in
MTR between the SLE and the HC groups (results not shown).3.1.2. DTI results
Themost signiﬁcant differences inDTImeasures betweenNPSLE and
HC were in RD (49% of WM skeleton), MD (42%) and FA (39%). The AD
differences were signiﬁcantly less extensive (18%). The differences in
DTI measures between the NPSLE and SLE groups were as extensive as
those found between the NPSLE and HC. This is in stark contrast to the
relatively minor MTR differences detected between these groups.
There were no signiﬁcant differences in any of the DTI measures be-
tween SLE and HC (results not shown).3.1.3. MTR/DTI overlap
MTR differences between NPSLE and HC, although extensive per se,
had only a moderate overlap with the widespread DTI differences be-
tween the two groups (rightmost column of Table 2). This can be also
qualitatively appreciated on Fig. 1: for example, extensive differences
in RD, MD and FA were observed in the genu of the corpus callosum
(yellow arrow), but were not accompanied by any MTR differences.
Overlap between regions with signiﬁcant MTR and DTI differences be-
tween NPSLE and SLE was negligible, as the regions with signiﬁcant
MTR differences between these populations were in themselves very
small (3% of skeletonized WM).3.2. Lesion analysis results
Fig. 2 shows the median, 25% and 75% quartile range for WM lesion
volumes and lesion counts in NPSLE patients, SLE patients and HC. Both
WM lesion volume and number of lesions were signiﬁcantly different
between NPSLE patients and HC (p-value b 0.01). No signiﬁcant differ-
encewas found between SLE andNPSLE patients or SLE patients andHC.3.3. Histogram analysis results
Fig. 3 shows the averageMD (panel a) andMTR (panel b) histograms
for NPSLE, SLE and HC. Table 3 shows the average and standard deviation
of peak heights and peak locations as well as the results of the non-
parametric statistical tests on the normalized histograms from all three
groups. MTR histogram peak heights of NAWMwere signiﬁcantly lower
in NPSLE compared to HC and SLE, whereas MD histogram peak heights
were signiﬁcantly higher. MTR histogram peak heights of NPSLE patients
were also signiﬁcantly lower than both those of SLE and HC. MTR peak
location was signiﬁcantly lower in NPSLE compared to HC and not signif-
icantly different from that of SLE. No signiﬁcant differenceswere observed
inMDandMTRpeakheights and locations of SLE histograms compared to
those of HC.4. Discussion
In this study we showed for the ﬁrst time that two different quanti-
tative MRI tools sensitive to microstructural properties of brainWM re-
ﬂect in a signiﬁcantly different manner the underlying tissue damage in
NPSLE. This is also theﬁrst study to investigate localizedMTR changes in
NPSLE patients compared to SLE patients with noNP symptoms and HC,
and to co-analyze these changes with DTI results from the same pa-
tients. Our results strongly suggest that DTI and MTI reﬂect pathogenic
processes in NPSLE that are only partially overlapping, hinting that
more than a single process is involved in the etiology of NPSLE. The sys-
tematic exclusion of hyperintense lesions from the analysis conﬁnes the
results of this study toNAWMand emphasizes the relationship between
the “invisible” tissue damage revealed by quantitativeMRImethods and
the disease, in addition to the “visible” damage seen in the lesions.
Table 2
Ratio of signiﬁcantly different voxels in between NPSLE vs HC and NPSLE vs SLE in AD, FA,
MD, RD and MTR to the total number of voxels in the skeleton (highlighted in gray) and
the ratio of signiﬁcantly different voxels overlapping in the signiﬁcant regions in two of
thesemetrics to the total number of voxels in the skeleton. Overlaps between DTI metrics
andMTR are shownas a ratio of signiﬁcantly different voxels inMTR. Overlaps between all
metrics with MD are shown as a ratio of signiﬁcantly different voxels in MD.
AD FA MD RD MTR Overlap MTR Overlap MD
AD 0.18 0.07 0.17 0.14 0.05 0.19 0.40
FA 0.39 0.24 0.34 0.15 0.52 0.57
NPSLE vs HC MD 0.42 0.37 0.14 0.51 1.00
RD 0.49 0.17 0.61 0.87
MTR 0.28 1.00 0.34
AD 0.29 0.08 0.24 0.20 0.00 0.10 0.54
FA 0.34 0.22 0.29 0.01 0.47 0.48
NPSLE vs SLE MD 0.46 0.39 0.01 0.38 1.00
RD 0.49 0.02 0.56 0.86
MTR 0.03 1.00 0.83
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sures, especially in MD and RD, there were signiﬁcant and spatially ex-
tensive differences between NPSLE and SLE, and between NPSLE and
HC, differences in MTR, albeit also spatially extensive, were found only
betweenNPSLE andHC,while almost noMTRdifferenceswere detected
between NPSLE and SLE (Fig. 1). This, taken with the fact that no differ-
ences, either in DTI or MTR, were found between HC and SLE, suggests
that MTR is sensitive to a microstructural pathomechanism that already
acts inWM in SLE patients but is not distinctive to NPSLE patients. Con-
versely, it is possible that DTI is more speciﬁcally sensitive to a micro-
structural feature that correlates only with NPSLE and not with SLE.
Moreover, the regions in which DTI differences between the groups
were observed only partially overlapped with the regions indicating
MTR differences, even though both methods showed roughly the
same sensitivity to the disease, expressed, e.g. by the fraction of voxels
in both methods exhibiting signiﬁcant differences between NPSLE and
HC.
MTR reﬂects the amount of exchange processes between “free”
water protons (or molecules) and water protons (or molecules)
bound tomacromolecular structures in tissue, e.g. myelin, cytoskeleton,
cell membranes, proteins and the extracellular matrix (Price et al.,
2011). In NPSLE, previous studies that reported MTR ﬁndings assignedFig. 2.Whitematter lesions shownwithwhite arrowonone axial slice of the FLAIR image froma
(right panel) in NPSLE patients, SLE patients and healthy controls shown with the median, 25%the drop in MTR in NPSLE patients to several potential mechanisms:
axonal injury, demyelination, microvascular ischemia, parenchymal
edema and gliosis (Bosma et al., 2004; Emmer et al., 2006; Emmer
et al., 2008). Emmer et al. suggested that edema was a more likely
cause for MTR changes in NPSLE patients since the reversible changes
in theMTR of the NPSLE patients corresponded to the improved clinical
status of the patients, and edema is more easily reversible with treat-
ment than, e.g. axonal damage, demyelination and gliosis (Emmer
et al., 2006). Histological evidence for many of the mechanisms
mentioned above was reported in a previous study that correlated
pre-mortemconventionalMRI observationswith post-mortemhistopa-
thology. In this study, the most frequently observed microstructural
damages were global ischemic changes and parenchymal edema
(Sibbitt et al., 2010). This also supports thehypothesis that parenchymal
edema, either cellular or interstitial, potentially contributes to the changes
inMTR observed in this study. It is also possible that inﬂammation-driven
microglial activation is linked to MTR changes in NAWM as has been hy-
pothesized with regard to MS (Moll et al., 2011).
Diffusivity measures obtained with DTI, on the other hand, reﬂect
the displacement of watermolecules on amicroscopic scale, and chang-
es in these measures reﬂect changes in tissue microstructure as well as
in properties of the diffusing medium, e.g. viscosity and molecular
crowding of the cytosol or the extracellular ﬂuid (Beaulieu, 2002).
Higher MD, RD and AD, as well as lower FA in NPSLE patients compared
to HC and SLE patients found in this study and in previous ones (Hughes
et al., 2007; Emmer et al., 2010; Jung et al., 2010; Zivadinov et al., 2013;
Schmidt-Wilcke et al., 2014) point to various underlying mechanisms,
including axonal loss, demyelination, edema, as well as microinfarcts
caused by the effect of corticosteroids or antirheumatic drugs and
acute inﬂammation in small vessels (Hughes et al., 2007; Emmer et al.,
2010; Jung et al., 2010; Schmidt-Wilcke et al., 2014). However, a salient
ﬁnding in our study is that the differences in RD between NPSLE and
SLE, and between NPSLE and HC, were much more extensive than the
differences in AD between groups. It should be noted thatMD is linearly
dependent on both RD and AD:MD ¼ 2RDþAD3 , and thus most of the ex-
tensive inter-group differences observed in MD in our study can be at-
tributed to the differences in RD. It has been argued that changes in
RDmostly reﬂect the creation ofmore space forwater to diffuse perpen-
dicularly to the axon propagation direction in the extracellular space in
WM, caused, e.g. by demyelination (Song et al., 2005). Although the hy-
pothesis of an exclusive link between radial diffusivity and demyelin-
ation has been challenged in conjunction with multiple sclerosis
(Wheeler-Kingshott and Cercignani, 2009), there is still a signiﬁcant
body of evidence to support the notion that an increase in RD reﬂects
mostly changes in the interstitial space. Thus, with demyelination only
as a secondary mechanism for WM microstructural damage in NPSLE
(Sibbitt et al., 2010), it is possible that the DTI changes we observed in
our study stem mostly from, e.g. edema. Differences in AD between
groups observed in this study were smaller than those observed in RDnNPSLE patient (left panel). Scatter plots ofWM lesion counts (middle panel) and volumes
and 75% quartile range.
Fig. 3. Average MD (left panel) and MTR (right panel) histograms from normal appearing white matter in the skeleton.
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stitial space, or represent intra-axonal changes that interfere with diffu-
sion along the axonal propagation direction caused by, e.g. axonal
degeneration and axonal loss, but thesewillmost likely cause a decrease
in AD rather than an increase (Budde et al., 2009; Wood et al., 2012). A
recent investigation of the DTI correlates of vasogenic edema using both
Monte-Carlo simulations and tissue phantom data showed that in-
creased extent of vasogenic edema could result in decreased FA, in-
creased RD and less signiﬁcantly increased AD, similarly to the results
in our study (Chiang et al., 2014).
From the diagnostic standpoint, the NPSLE subject group in our
study consisted exclusively of patients with active complaints at the
time of the MRI examination. This may explain the more extensive
changes observed in our study, compared to previous DTI-TBSS studies
on NPSLE (Emmer et al., 2010; Junget al., 2010; Schmidt-Wilcke et al.,
2014). Several regions which showed signiﬁcant decreased FA were
also reported in previous studies, such as the inferior fronto-occipital fas-
ciculus, the fornix, the posterior limb of the internal capsule (corticospinal
tract), the anterior limb of the internal capsule, inferior longitudinal fas-
ciculus, inferior fronto-occipital fasciculus, cingulum, corpus callosum, su-
perior longitudinal fasciculus, and the anterior corona radiata (Emmer
et al., 2010; Jung et al., 2010; Zimny et al., 2014), while some were ob-
served here for the ﬁrst time: the external capsule, cerebral peduncle,
and posterior thalamic radiation. It is thus plausible that the microstruc-
tural tissue damage revealed by the DTI measures is non-speciﬁc and
based on our results, has a sharp onset correlated with the NPSLE
symptoms.
Histograms ofMTR andDTImeasures in the skeletonizedWMoffer a
non-spatially speciﬁc assessment of the differences among the various
groups. Histograms of MTR and DTI measures have been used to evalu-
ate changes in several previous studies (Bosma et al., 2000a; Bosma
et al., 2000b; Bosma et al., 2003; Bosma et al., 2004; Emmer et al.,
2006). Peak heights in normalized histograms are typically inversely re-
lated to the variance (peak width) of the measure represented in the
histogram, while the peak location, or the most frequently observed
value, is typically correlated (but not identical) to the mean value of
the measure in the histogram, and thus is more directly related to the
values observed in a spatially-resolved manner in the difference mapsTable 3
MTR andMD histogram peak heights in NPSLE patients, SLE patients and healthy controls.
NPSLE patients SLE patients Healthy controls
MTR peak height in NAWM 63.3 ± 8.7⁎⁎(⁎) 77.8 ± 8.3 80.0 ± 12.4
MTR peak location in NAWM 37.11 ± 2.26⁎⁎ 38.78 ± 2.22 39.64 ± 2.41
MD peak height in NAWM 126.7 ± 21.7⁎ 146.7 ± 20.6 147.9 ± 17.2
MD peak location in NAWM
(×10−3 mm2/s)
0.76 ± 0.03⁎(⁎) 0.73 ± 0.04 0.74 ± 0.02
⁎ p-Value b 0.05 versus healthy controls.
⁎⁎ p-Value b 0.01 versus healthy controls.
(⁎) p-Value b 0.05 versus SLE.in Fig. 1. Here we show histogram results both for comparison purposes
to previous studies, as well as to present more accurate global changes
in DTI and MTR than previously shown, in that they are speciﬁc to the
core of WM tracts, i.e. clean from partial volume with gray matter and
CSF, as well as to NAWM, thus avoiding the confound of WM lesions,
whichwere included in histograms shown inmost previous studies, ex-
cept for Emmer et al. (2006). The signiﬁcant difference between the
peak location of the MD histogram of NPSLE and that of both SLE and
HC corroborates the spatially-resolved results shown earlier in our
TBSS analysis. Similarly, the MTR histogram peak location in NPSLE
was signiﬁcantly different from that of HC but not from that of SLE, al-
though this can be attributed to the variance in the MTR measures. Dif-
ferences observed in histogram peak heights in both MTR and DTI were
in line with previous studies (Bosma et al., 2000a; Bosma et al., 2000b;
Bosma et al., 2003; Emmer et al., 2006).
Although this study mostly focused on microstructural changes in
NAWM in NPSLE and SLE, we performed a detailed focal lesion analysis,
which conﬁrms previous ﬁndings of signiﬁcant differences in NPSLE pa-
tients compared to SLE and HC (Appenzeller et al. (2008b); Kozora and
Filley, 2011). It is impossible to exclude the effect that WM lesions have
on the disease outcomeof NPSLE, although direct relationship is difﬁcult
to establish (Luyendijk et al., 2011). In the context of our study, individual
mapping of WMH and their systematic exclusion from the skeletonized
WM analyses helped demonstrate the signiﬁcant role that alterations in
NAWM have in NPSLE.
This study was subject to many limitations and challenges. Besides
the small cohort size of this study, which limits its statistical power,
one of the most severe limitations of this study is the lack of diagnostic
differentiation between ischemic and inﬂammatory NPSLE patient
groups. It has been hypothesized that these phenotypes may result in
a different set of disease effects on the brain, and by combining these
groups, we measured an averaged overall effect of SLE and NPSLE on
WM microstructure, without having the speciﬁcity to assign the
resulting outcomes to inﬂammation or ischemia.We intend to separate-
ly investigate the effect of inﬂammatory and ischemic NPSLE in a longi-
tudinal study in order to provide a multimodal MRI characterization of
the damage caused by inﬂammation or ischemia. Another limitation of
this study was the heterogeneity of NPSLE syndromes observed in our
patients, which subsequently may lead to a large variability in the loca-
tion and the severity of the tissue microstructural correlates. In the fu-
ture, we plan to continue our multimodal investigation of SLE and
NPSLE with more homogenous subgroups of patients, in the hope that
this could lead to a better characterization of the link between NPSLE,
and tissue damage in speciﬁc areas of the brain resulting in speciﬁc
symptoms.
Lastly, only 6 NPSLE patients out of the total 9were scannedwithin a
year of the ﬁrst onset of NP symptoms, while the other 3 patients were
diagnosed as NPSLE 3–6 years prior to theMRI scans. Longer disease du-
rations may have probably added confounding factors such as accumu-
lated tissue damage caused by previous NPSLE episodes as well as
effects caused by longer treatment. This study could have indeed
343E. Ercan et al. / NeuroImage: Clinical 8 (2015) 337–344beneﬁtted from a tighter range of disease durations, however it should
bementioned that given the relative low incidence of NPSLE in the gen-
eral population, we focused on scanning NPSLE patients with active
symptoms, rather than limiting it further to patients with ﬁrst occur-
rence of NP symptoms.
5. Conclusions
In conclusion, this study supports the notion that microstructural tis-
sue changes inNAWMinNPSLE are heterogeneous, and that these chang-
es give rise to a complex MRI picture as seen by two distinct quantitative
MRI tools. We showed the potential usefulness of spatially-resolved co-
analyses of MTR and DTI data, which we hope that in the future, may
help detect local effects of the different pathological mechanisms in
NPSLE and their link to speciﬁc neuropsychiatric symptoms, and can
thus be useful for designing better diagnostic procedures for NPSLE.
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